Patients with cryptogenic stroke treated with routine transcatheter patent foramen ovale closure have increased 4-year stroke risk.

"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

Axxcess Wealth Management LLC lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 14.2% during ...

It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under ...

Edwards categorizes its therapies and technologies into four categories: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural ...

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, showcased 2-year follow up data from ...

Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...